Medtronic to Acquire Intersect ENT for ~$1.1B Published: Aug 6, 2021 | Tags: Medtronic, Intersect ENT, ~$1.1B Kite Signs a License Agreement with Appia to Develop Allogeneic Cell Therapies for […]readmore
Tags : Intersect ENT
Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by […]readmore